Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly's head-to-head with Victoza raises a red flag for diabetes drug dulaglutide
Lilly's head-to-head with Victoza raises a red flag for diabetes drug dulaglutide
Lilly's head-to-head with Victoza raises a red flag for diabetes drug dulaglutide
Submitted by
admin
on June 9, 2014 - 1:21pm
Source:
Fierce Biotech
News Tags:
Victoza
Eli Lilly
diabetes
dulaglutide
Headline:
Lilly's head-to-head with Victoza raises a red flag for diabetes drug dulaglutide
Do Not Allow Advertisers to Use My Personal information
